$ACHN News 6 stocks to watch 2:35 p.m. Oct. 29, 2014 -

New Post Public Reply Private Reply Replies (0) Message Board

Oct 31, 2014 at 1:00 PM

$ACHN News

6 stocks to watch 2:35 p.m. Oct. 29, 2014 - The Trading Deck
6 stocks to watch 3:10 p.m. Oct. 22, 2014 - The Trading Deck
6 stocks to watch 3:36 p.m. Oct. 9, 2014 - The Trading Deck
10 Nasdaq stocks with returns of at least 240% in 2014 5:38 p.m. Sept. 11, 2014 - Philip van Doorn
5 stocks to watch 1:38 p.m. Sept. 3, 2014 - The Trading Deck
Six stocks to watch 1:47 p.m. Aug. 27, 2014 - The Trading Deck
S&P 500 reaches firmer technical ground 11:30 a.m. Aug. 18, 2014 - Michael Ashbaugh
Stocks trim Ukraine-inspired fall, post weekly gain 4:08 p.m. Aug. 15, 2014 - Anora Mahmudova
In focus: New highs premature? 9:03 p.m. June 18, 2014 - Lawrence G. McMillan
Achillion shares up; FDA lifts hold on hepatitis C drug 10:25 a.m. June 10, 2014 - Anna Prior
U.S. stock futures sink on shutdown fears 8:38 a.m. Sept. 30, 2013 - Barbara Kollmeyer
Zynga shares rise, Achillion drops after hours 5:51 p.m. July 1, 2013 - Wallace Witkowski
FDA puts Achillion Hep C drug on clinical hold 5:16 p.m. July 1, 2013 - MarketWatch.com
Five stocks making moves 3:12 p.m. Feb. 14, 2013 - The Trading Deck
Thursday’s top gaining & declining stocks 5:02 p.m. Sept. 27, 2012 - Greg Morcroft
Achillion sees progress in hepatitis C study 9:04 a.m. Sept. 27, 2012 - MarketWatch.com
Vertex to advance testing of oral HCV drug regimen 10:34 a.m. Sept. 25, 2012 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 4:37 p.m. Sept. 19, 2012 - MarketWatch
Achillion, Idenix move on price target changes 10:29 a.m. Sept. 19, 2012 - Val Brickates Kennedy
Gilead boosted as analysts hike price targets 10:42 a.m. Sept. 17, 2012 - Val Brickates Kennedy

Biggest Movers in Healthcare Stocks Now – TRNX MDCO ACHN AMGN 7:30 a.m. Oct. 28, 2014 - InvestorPlace.com
Speculating on Achillion's Boom-or-Bust Hep C Drug Study Results 8:39 a.m. Oct. 22, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – AMGN GILD REGN ACHN 2:00 p.m. Oct. 21, 2014 - InvestorPlace.com
Must See Charts: 4 Biotech Stocks to Watch in a Market Snapback 1:50 p.m. Oct. 17, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – REGN ACHN CBPO HZNP 8:45 a.m. Oct. 17, 2014 - InvestorPlace.com
Achillion Pharmaceuticals, Inc. Shares Trading At Highs Following Positive Comments From FBR Capital 1:28 p.m. Oct. 8, 2014 - benzinga.com
Top 5 Biotech Stocks Over The Past Year 1:28 p.m. Oct. 6, 2014 - benzinga.com
Insider Selling Jumps as Market Volatility Highest Since Summer 8:23 a.m. Oct. 4, 2014 - 247WallSt.com
Biggest Movers in Healthcare Stocks Now – ACHN THRX AGN VRTX 1:30 p.m. Oct. 3, 2014 - InvestorPlace.com
Biotech Stock Mailbag: Seattle Genetics, Achillion, Catalyst Pharma 9:41 a.m. Oct. 3, 2014 - TheStreet.com
Achillion: Positioned To Deliver The Last Clinical Stage Nuc To The Highest Bidder 2:48 p.m. Oct. 2, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 10/1/14: SNTA, AGCO, RSG, DWA 8:28 a.m. Oct. 2, 2014 - Seeking Alpha
Achillion Pharmaceuticals, Inc. Less Attractive Amid Johnson & Johnson/Alios BioPharma Deal 11:19 a.m. Sept. 30, 2014 - benzinga.com
J&J Buying Alios, Going Up Against Gilead 11:02 a.m. Sept. 30, 2014 - Investors Business Daily
Why J&J Expands Antiviral Franchise but Doesn't Buy Achillion, Novavax 9:49 a.m. Sept. 30, 2014 - TheStreet.com
InsiderInsights.com Daily Round Up 9/26/14: CONN, AEO, OPK, RSG 9:20 a.m. Sept. 29, 2014 - Seeking Alpha
Following Biotech Stocks After Price Declines Of Greater Than 50% 4:03 p.m. Sept. 25, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 9/23/14: Apple, Ulta, Intersections, Republic Services 10:42 a.m. Sept. 24, 2014 - Seeking Alpha
If Achillion's Hep C Nucleotide Isn't Best In Class, The Stock Is Worth Low Single Digits 8:00 a.m. Sept. 16, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – ACHN BLUE LCI SLXP 7:30 a.m. Sept. 16, 2014 - InvestorPlace.com

Critical Alerts For NetSuite, CVS Caremark, Netflix, VeriFone Systems and Achillion Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Oct. 27, 2014 - PR Newswire - PRF
Achillion to Present Updated Clinical HCV Data on ACH-3102 and Preclinical Profile of ACH-3422 at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting 10:24 a.m. Oct. 8, 2014 - GlobeNewswire
Critical Alerts For Achillion Pharmaceuticals, Dreamworks Animation, SunEdison, El Pollo Loco and Whole Foods Market Released By InvestorsObserver 9:31 a.m. Sept. 30, 2014 - PR Newswire - PRF
Biotech Stocks Technical Data - Medivation, Galectin Therapeutics, Ironwood Pharma, Achillion Pharma, and PDL BioPharma 9:05 a.m. Sept. 16, 2014 - PR Newswire - PRF
Critical Alerts For Achillion Pharmaceuticals, LightInTheBox, VoxelJet, Whole Foods Market and Disney Released By InvestorsObserver 9:31 a.m. Sept. 15, 2014 - PR Newswire - PRF
Technical Updates, Operational Milestones, Product Upgrades, and Energy Saving Programs - Research Reports on Achillion, DE, Honeywell, Lockheed Martin and L-3 Communications 8:35 a.m. Sept. 9, 2014 - PR Newswire - PRF
Global Hepatitis C Market 2014-2018 9:58 p.m. Sept. 8, 2014 - PR Newswire - PRF
Reveal Insider Trading for Facebook, Plug Power, Achillion Pharmaceuticals, Apple, Twitter, and Intel 8:55 a.m. Sept. 2, 2014 - PR Newswire - PRF
Critical Alerts For Achillion Pharmaceuticals, Intel, YY, JA Solar and Skullcandy Released By InvestorsObserver 9:31 a.m. Aug. 26, 2014 - PR Newswire - PRF
Biotechnology Stocks to Keep an Eye On 9:02 a.m. Aug. 20, 2014 - ACCESSWIRE
New Drug Launches, Technical Updates, New Facility, Clinical Trials Data, and Dividend Declarations - Research Reports on Covidien, Mylan, Baxter, Achillion and Perrigo 8:40 a.m. Aug. 20, 2014 - PR Newswire - PRF
Achillion Granted U.S. Patent for ACH-3102 and Structurally Related NS5A Inhibitors 4:06 p.m. Aug. 19, 2014 - GlobeNewswire
Achillion Achieves 100 Percent Sustained Virologic Response Rate (SVR4) From an Eight Week Phase 2 Trial Evaluating a Ribavirin-Free Regimen of ACH-3102 and Sofosbuvir for Genotype 1 HCV ("Proxy Study"

7:00 a.m. Aug. 15, 2014 - GlobeNewswire
Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics 8:50 a.m. Aug. 13, 2014 - PR Newswire - PRF
Achillion Reports Second Quarter and Six Month 2014 Financial Results 4:06 p.m. Aug. 7, 2014 - GlobeNewswire
Critical Alerts For Achillion Pharmaceuticals, Synergy Resources, Invensense, JinkoSolar, and Harley-Davidson Released By InvestorsObserver 9:31 a.m. Aug. 5, 2014 - PR Newswire - PRF
Critical Alerts For Exelixis, Rocket Fuel, Netflix, Johnson & Johnson, and Achillion Pharmaceuticals Released By InvestorsObserver 9:31 a.m. July 15, 2014 - PR Newswire - PRF
Technical Data on Health Care Sector Equities -- Research on Achillion Pharma, Novavax, Dendreon, and Exelixis 7:00 a.m. July 10, 2014 - PR Newswire - PRF
Agreements, NDA Submissions, FDA Approvals, Enrollment Updates, and Index Inclusions - Analyst Notes on Jazz Pharmaceuticals, Vertex, NPS, StemCells and Achillion 5:50 a.m. July 7, 2014 - PR Newswire - PRF
Achillion Pharmaceuticals Added to the Russell 2000 and Russell Microcap Indexes 4:06 p.m. July 1, 2014 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Parents Champion Meta's Online Safety Agreement

Any old-timer in the market game will tell you this: safeguarding the next generation runs deeper than just chasing profits. A recent poll by the Coalition to Empower our Future reveals something that ain’t too surprising if you’ve been paying attention. Parents all over the nation are nodding along to Meta’s new move to bolster online protections for younger folks....

Potomac Edison Eyes Rate Hike for System Overhaul

FirstEnergy's Potomac Edison Pushes for Rate Adjustment The walls are closing in on the energy sector, and Potomac Edison is seizing the moment. With their proposed $52.8 million rate adjustment, they're not only aiming to keep the lights on but to power up their entire infrastructure game. It's a gutsy move, particularly in volatile times. The Price Tag: Weighing Costs...

Local Climate Resilience Gains Urgency in the Southwest

Local Impact Means Taking Climate Change Personally If you haven't felt it yet, you will. Climate change isn't just a global headline anymore—it's a daily reality that’s reshaping life where you stand. David W. DuBois, New Mexico's top climatologist, is sounding the alarm this time on the new Net Zero Speaks episode, saying it's on us to use local climate knowledge to...

Halloween 2026: Gemmy's Animatronics Add Thrills

Halloween's New Twist with Gemmy's Animatronics Well, just when you thought Halloween couldn't get any more over the top, here comes Gemmy with their 3-foot tall animatronic characters ready to give your trick-or-treat scene that extra jolt. These aren't just any run-of-the-mill decorations. Nope, they come with a twist—an industrial-strength twist of scares and sweets...

ASU Teams Up for National Manufacturing Workforce Push

ASU's Role in Reviving American Manufacturing The Foundry School is a big hit for Arizona State University (ASU) as it joins hands with seven other top-tier universities under the U.S. Departments of State and Labor's initiative. This project is all about sculpting the future players of American manufacturing. In a scene highlighted by the Vice President and girded by...

TrailBlazer Magazine Snags a Tribune for In-House Design

Who Knew? Design Awards Aren't Just for Pretty Pictures TrailBlazer Magazine gets a pat on the back from GDUSA's 2026 Inhouse Design Awards, a nod to top-notch design work. With over 4,000 entries across the board, getting into the top 10 percent is like finding a steakhouse with zero line on a Friday night. Not exactly common, right? Design Worth Cheering For The winning...

GoDaddy Faces Class Action: Investor Stakes High

GoDaddy's Legal Turbulence: What's at Stake? Sometimes riding the stock wave can hit unexpected snags, and that's what's up with GoDaddy right now. They're stuck in the middle of a securities deception storm that's sending shivers down the spine of many an investor. The Class Action Lawsuit's Core Here's what you need to know: GoDaddy, with its ticker NYSE:GDDY, is...

Hyundai's Revolutionary US Steel Mill Set for 2029 Rollout

Hyundai's Major Steel Move: A Multibillion-Dollar Stake The steel industry scene in the U.S. just got a lot hotter with Hyundai's announcement of a $5.8 billion Electric Arc Furnace-based integrated steel mill in Louisiana. This game-changing project isn’t just a headline; it’s a concrete step towards beefing up the U.S. manufacturing backbone. Talk about...

PrimeBOT Shines at IFA 2026 with Innovative Awards

A New Chapter in Home Robotics In today's tech-centric world, newcomers often confuse flash with substance. But every now and then, you catch a glimpse of something that might just change how the world spins. At this year's IFA 2026, PrimeBOT didn't just dip its toes into the limelight—it cannonballed right in, drumming up some serious buzz with its PrimeBOT T1 and...

AVEX Faces Lawsuit Over IPO Missteps

By Riley Hayes Updated Sep 4, 2026 Category News Views 3

Legal Storm Brewing with AEVEX's IPO Disclosures Whatever happened to straightforward honesty in business? AEVEX Corp. (NYSE: AVEX) might have forgotten that chapter judging by fresh allegations in their midst. Investors who bought AVEX Class A common stock between April 17 and June 4, 2026, have been hit with a curveball: a looming class action lawsuit for securities...